Legend Biotech Corp

Legend Biotech Corp

World Rank (Jan-05-2024)
1,758
Market Cap (Jan-05-2024)
9.316 Billion USD
World Rank (Jul-30-2023)
1,285
Market Cap (Jul-30-2023)
13.797 Billion USD
World Rank (Jan-07-2022)
2,553
Market Cap (Jan-07-2022)
6.825 Billion USD
World Rank (Jan-01-2021)
3,868
Market Cap (Jan-01-2021)
3.524 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 500
Headquarters Country
USA
Nasdaq / NYSE Code
LEGN
Market Cap (Mar-08-2026)
3.48
Employee Count
1,390
Employee Count as of Date
As on 2022
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
117 Million USD
Annual Operating Income in USD
-458 Million USD
Annual Net Income in USD
-446 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,330 Million USD
Total Liabilities in USD
586 Million USD
Total Equity in USD
744 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Biopharmaceutical
Biotechnology
Healthcare
Company Website
LEGEND BIOTECH CORP
Yahoo
Yahoo @ Nasdaq
Company Profile

Legend Biotech is a Multinational Biopharmaceutical company. It is focused on continuous innovation in the field of cell therapy and also future focused on emerging technologies that can help address some of the most chronic and life threatening diseases. The company annual revenue is 117 million USD and 1,390 employees as on 2022. The headquarters is in USA.

Annual Results Summary

LEGEND BIOTECH CORP - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022117-458 (Loss)-446 (Loss)
Dec-202189-371 (Loss)-386 (Loss)
Dec-202075-226 (Loss)-303 (Loss)
Dec-201957-135 (Loss)-132 (Loss)
Dec-201849-15 (Loss)-2 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,330 Million USD.

Total Liabilities as on Dec-2022 was 586 Million USD.

Total Equity as on Dec-2022 was 744 Million USD.

Founded Year
2014
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share